Übersicht der SEO Analyse
Metaangaben
92% 
Seitenqualität
55% 
Seitenstruktur
100% 
Verlinkung
25% 
Server
40% 
Externe Faktoren
100% 
SEO Score
Antwortzeit
0,05 s
Dateigröße
167,10 kB
Wörter
13239
Medien
168
Anzahl Links
418 Intern / 11 Extern

To-do Liste mit SEO Optimierungen

Meta-Angaben im HTML

Titel
(Extrem wichtig)
CLL Topics: Therapies, Research and Patient Education for Chronic Lymphocytic Leukemia
Der Titel sollte kürzer als 580 Pixel sein. Er ist insgesamt 817 Pixel lang. Jetzt optimieren
Es gibt keine Wortwiederholungen im Titel.
Meta-Description
(Extrem wichtig)
CLL Topics dedicated to the fight against chronic lymphocytic leukemia - patient education and support, clinical research and new therapies
Die Meta-Description hat eine optimale Länge. (855 Pixel von maximal 1000 Pixel Länge)
Crawlbarkeit
(Extrem wichtig)
Es gibt keine Probleme beim Zugriff auf die Webseite.
Canonical Link
(Wichtig)
Es ist kein Canonical Link angegeben.
Sprache
(Wenig wichtig)
Im Text erkannte Sprache: en
Serverstandort: Spanien
Eine oder mehrere der angegebenen Sprachen sind nicht in ISO Norm (de, de-at, en, usw.)
Die Sprache ist nicht im HTML Markup angegeben.
Alternate/Hreflang Links
(Wenig wichtig)
Die Seite nutzt keine Alternate Links.
Weitere Metatags
(Wenig wichtig)
Es gibt keinen rel next Meta Tag auf der Seite.
Es gibt keinen rel prev Meta Tag auf der Seite.
Domain
(Wenig wichtig)
Die Domain ist keine Subdomain.
Die Länge der Domain ist gut.
Die Domain enthält keine Umlaute.
Seiten URL
(Wenig wichtig)
In der URL wurden keine Parameter entdeckt.
In der URL wurde keine Session ID entdeckt.
Die URL hat nicht zu viele Unterverzeichnisse.
Zeichensatzkodierung
(Wenig wichtig)
Die Zeichensatzkodierung ist nicht im HTTP Header angegeben.
Die Angaben zur Zeichensatzkodierung (UTF-8) sind fehlerfrei.
Doctype
(Nice to have)
Die Doctype Angabe XHTML 1.0 Transitional ist korrekt angegeben.
Die Doctype Angabe befindet sich an erster Stelle im HTML-Code.
Favicon
(Nice to have)
Es ist kein Favoriten Icon (Favicon) im HTML-Code verlinkt.

Meta Tags

NameWert
DescriptionCLL Topics dedicated to the fight against chronic lymphocytic leukemia - patient education and support, clinical research and new therapies
Keywordspatient education, CLL, chronic lymphocytic leukemia, volunteer, therapy choices, chemotherapy, immunotherapy, clinical trial, chemoimmunotherapy, stem cell transplant, bone marrow, blood cancer, leukaemia, vaccine, CLLTopics.org
authorP. C. Venkat
copyright© 2002-2007 CLL Topics, Inc.
Content-Typetext/html; charset=utf-8
Content-Script-Typetext/javascript

Analysiere jetzt kostenlos bis zu 1.000 Unterseiten von clltopics.org!

Kostenlos registrieren
Die Nutzung des Basis Accounts ist zeitlich unbegrenzt möglich

Seitenqualität

Inhalt
(Extrem wichtig)
Der Seiteninhalt ist mit 13239 Wörtern sehr lang. Es macht eventuell Sinn den Text auf mehrere Seiten aufzuteilen.
Es befinden sich 6 Text-Duplikate auf der Seite:
  • Duplikat 1: Please do remember that the writers of the articles on CLLTopics.org a...
  • Duplikat 2: All materials contained on this site are protected by United States co...
  • Duplikat 3: However, you may download and print material from CLLTopics.org exclus...
Der Text besteht zu 25.5% aus Füllwörtern.
Worte aus dem Titel werden im Text wiederholt.
Wörter aus der H1 Überschrift werden im Text der Seite verwendet.
Im Text befindet sich eine Aufzählung, dies deutet auf eine gute Textstruktur hin.
Es wurden 157 Fließtextblöcke auf der Seite gefunden.
Es wurden keine Platzhalter Texte bzw. Bilder gefunden.
Die durchschnittliche Satzlänge ist mit 19.99 Wörtern gut.
Frames
(Extrem wichtig)
Die Seite hat kein Frameset.
Mobile
(Wenig wichtig)
Es ist kein Viewport angegeben.
Es ist kein Apple-Touch Icon angegeben.
Die Webseite lädt 4 Javascript Dateien, dies kann die Ladezeit negativ beeinträchtigen.
Bold- und Strongtags
(Wenig wichtig)
Einige der Tags sind zu lang. Mit 177 Zeichen ist dieser länger als 70 Zeichen:
"for the latest information on research, clinical trials and best practices — timely information that c..."
Bilder Optimierung
(Wenig wichtig)
Bei 22 Bildern fehlt das Alt-Attribut. Der Inhalt von Alt-Attributen wird von Suchmaschinen auch als Text gewertet und ist wichtig für die Bildersuche.
Soziale Vernetzung
(Nice to have)
Es befinden sich wenige Social-Sharing Möglichkeiten auf der Seite. Mit Plugins zum Teilen, kann die Reichweite der Seite in sozialen Netzwerken erhöht werden.
Zusätzliches Markup
(Nice to have)
Es wurde kein zusätzliches Markup gefunden.
HTTPS
(Wenig wichtig)
Das Protokoll HTTPS zur sicheren Übertragung von Daten wird nicht verwendet.

Medienliste

URLALT-AttributeTitel
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
/nav/NavBanner_r1_c1.jpgCLL Topics Banner: Therapies, Research and Patient Education for Chronic Lymphocytic Leukemia
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
/nav/NavBanner_r2_c1.jpgKein ALT-Attribut angegeben
/nav/NavBanner_r2_c2.gifCLL Topics Home
/nav/NavBanner_r2_c3.gifNavigation
/nav/NavBanner_r2_c4.gifTopics Alert
/nav/NavBanner_r2_c5.gifLearning Tools
/nav/NavBanner_r2_c6.gifAbout Us
/nav/NavBanner_r2_c7.gifFeedback
/nav/NavBanner_r2_c8.jpgFeedback
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
/nav/NavBanner_r3_c8.jpgKein ALT-Attribut angegeben
/nav/NavBanner_r3_c9.gifFull Menu
/nav/NavBanner_r3_c10.jpgKein ALT-Attribut angegeben
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
/nav/NavBanner_r4_c9.jpgKein ALT-Attribut angegeben
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
/nav/NavBanner_r5_c2.jpgKein ALT-Attribut angegeben
http://www.clltopics.org/nav/spacer.gifKein ALT-Attribut angegeben
...loads/updates_subdomain/UpdatesLogin.gifCLL Topics Updates
/images/worldballoonsmall.gifCLL Topics World Balloon
/images/floretandleafelement2.gifdoor ornament
http://www.clltopics.org/mail/mailHPat.gifemail
/images/TreegoldS.jpgtree silhouette
/images/decorativeornament.gifdecorativeornament
http://www.clltopics.org/images/Zen.gifZen Sunset
http://www.clltopics.org/images/wave1.gifwave
http://www.clltopics.org/mail/edat.gifemail
/images/lilium_steelfoil.jpgSteelfoil Lillies
http://www.clltopics.org/mail/mailHPat.gifemail
http://www.clltopics.org/mail/mailHPat.gifemail
http://www.clltopics.org/images/orchid1.jpgOrchid
/images/o_g_blue.jpgornate embroidery
/images/7blu5dot.gifbludots
/images/FLWWindow101SM.gifFLW art glass
/images/7blu5dot.gifbludots
/images/W3CXHTML10.gifValid XHTML 1.0 Transitional
http://www.clltopics.org/images/W3CCSS.gifValid CSS!
/images/ImpArchwaySm2.jpgmuseum alcove
/images/Logo_40wht.gifGoogle Logo
/images/AtomzLogo129x52.gifAtomz Logo
/images/7blu5dot.gifbludots
/images/roseLSFObit.jpgObituary
/images/ornate-railing.gifObituary
/images/PurplePentacube.jpgPurple Pentacube
/images/Mandelpart.pngMandelbrot Part
/images/LongLifeSM.giflong life
/images/redflowerSM.gifred
/images/HematopoieticstemcellsSM.gifhematopoeitic stem cells
/images/Splash3SM.gifsplash
/images/cutter2RdSM.gifabstract
/images/flagPuSM.gifDirections
/images/SpiralWorldsSM.jpgProgressive Spiral
/images/TiffMedPur01SM.gifTiffany glass
/images/QOLSurveySM2.gifQOL Survey
http://www.clltopics.org/images/CompWSM.gifuseful comparison?
/images/HematopoieticstemcellsBLQMSM.gifhematopoeitic stem cells
/images/3redringsSM.gifrings
/images/FLWWindow03180FSM.giffaded glass
/images/shellglass1SM.gifshell glass
/images/OceanRainbowSM.jpgrainbow
/images/BBfaceBlSM.jpgdial
/images/FLWWindow02SM.gifGlass
/images/mouseSkeletonYlSM.gifX-ray mouse
/images/FLWArtGlassSM.gifart glass
/images/3greenringsSM.gifrings
/images/GoldHorseSM.gifequine outline
/images/newlightBSM.gifnew light
/images/chemomechanismSM.gifmolecular markers
/images/RedCascadeSqSM.jpgelectric cascade
/images/FractalCascadeSqSm.jpgfractal cascade
http://www.clltopics.org/images/DawnSky.jpgDawn Sky
/images/stemcellsGRSM.jpgstem cells
http://www.clltopics.org/images/OCCCSM.jpgOrlando CC
/images/BlueRoseSM.giffractal blue rose
http://www.clltopics.org/images/TregSm.gifT-regs
/images/abacusSm.gifx-ray abacus
/images/bluecapsule.gifcapsule
/images/p53geneSM.gifp53 Gene Map
http://www.clltopics.org/images/cukesSM.gifepitopes
/images/StaphylococcusAureusSM.gifbacterial culture
/images/PurpleCascadeSqSm.jpgfractal cascade
/images/silkredSM.gifabstract
http://www.clltopics.org/images/EBVSm.gifEBV
/images/virusblueSM.gifVirus in Blue
http://www.clltopics.org/images/RBCsSMV.gifRBCs
/images/CBandSnoopy2SM.gifcompanions
http://www.clltopics.org/images/LHTbtn.jpgtomato button
/images/2applesnokumquat.gifapples to apples
/images/LeonardoProportionStudy.gifLeonardo Proportion Study
/images/athletic_shoes.jpgsneakers
/images/Roadblock.giftraffic barrier
/images/MedicalSignBlSM.jpgcadeseus
/images/EGCGstrGBSm.gifEGCG molecule
/images/appleskumquatSM.gifapples and kumquat
/images/UPMCFCRLiteSM.gifUPMC Cancer Center
/images/rouletteSM.jpgroulette
/images/halffullglassSM.jpghalf-full glass
http://www.clltopics.org/images/fluSM.gifH5N1
http://www.clltopics.org/images/wolfSM.jpgcute wolf
http://www.clltopics.org/images/Bcl2SM.jpgbcl2
/images/influenzaSM.gifflu virus
/images/RedTCellSm.gifT-cell red
http://www.clltopics.org/images/EGCGstr.gifEGCG
/images/LabcoatStethOrSM.giflabcoat
/images/binoculars2.jpgbinoculars
/images/evergreenXplantsSM.giftransplants
/images/HematopoieticstemcellsPuSM.gifhematopoietic stem cells
http://www.clltopics.org/images/Hsp90SM.gifhsp90
/images/YelloBrickRoadSM.gifYellow Brick Road
/images/CampathNeulastaSM.gifmolecular montage
/images/antibodyGbbSM.gifantibody diagram
/images/FishlittleblockInv.gifprognostic symbols
/images/YloBrkRdGrSM.gifbrick road
/images/campath6.gifCampath Molecule
/images/raistageriskadj2.gifStaging is passe
/images/Fishlittleblock.gifprognostic symbols
/images/FCRIsThisACureH.gifIs FCR a Cure
/images/TwinFish.gifsymbolic fish
/images/oralcarePSM.jpgoral care
/images/jigsawBkSM.gifjigsaw puzzle
/images/LobsterSmall.giflobster
/images/chromatinSM.gifchromatin
/images/whichkeyfitsSm.gifkey lock puzzle
/images/ornate-railing.gifrailing
/nav/CompassCornerSm.gifGuideCompass
http://www.clltopics.org/nav/arrowtop.gifKein ALT-Attribut angegeben
/nav/navyfooterblocklj2006.gifCLL Topics - Dedicated to the Fight Against Chronic Lymphocytic Leukemia
/images/Logo07MagGlassmicro.gifTopics Search
/images/HJplaque4.gifjournal
http://www.clltopics.org/images/SixStar.gifSix Point Star
/images/roosterheads.gifroosterheads
/images/Ivy-league-arch.jpgIvy League Sepia
http://www.clltopics.org/images/columnT.gifGreek Column
/images/WorldmoneySM.jpgWorld Money and Globe
http://www.clltopics.org/images/swfSM.gifspiral
http://www.clltopics.org/images/oa2.gifacanthus
/images/VietnamAOSM.gifVietnam
http://www.clltopics.org/images/mayoSM.jpgmayo building
http://www.clltopics.org/images/mfSM.gifmulticolor fixture
/images/colorfishSM.giffish
http://www.clltopics.org/images/ducksSM.gifducks
/images/campath9.gifCampath molecule
http://www.clltopics.org/images/fcyBLSM.gifflow cytometry
/images/lymphaticsystemSM.giflymphatic system
/images/adhesion4SM.gifcell micrograph
/images/cytogenetics3SM.gifgene plot
/images/adhesion5SM.gifcell micrograph
/images/sunsquareSM.gifsunsquare
/images/mitochondrionSm.gifmitochondrion
http://www.clltopics.org/images/RBCsSMV.gifRBCs
http://www.clltopics.org/images/epoSM.gifEPO
/images/inflammationSM.gifinflammation
/images/evolutiondiagSM.gifevolution diagram
http://www.clltopics.org/images/shells1.gifshells
/images/CBandSnoopyRoSM.gifcompanions
/images/LanternF2.giflantern

Seitenstruktur

H1 Überschrift
(Extrem wichtig)
CLL Topics Home Page
Die H1-Überschrift ist perfekt.
Überschriften
(Wichtig)
Die Überschriftenstruktur ist fehlerfrei.

Überschriftenstruktur

Überschriften HierarchieInhalt
H1 CLL Topics Home Page
H2 Welcome to CLL Topics
H3 Press Coverage
H3 Useful Tools:
H4 September 3, 2012
H4 Who Are We?
H4 Key Pointers
H4 About Our Articles
H4 Summary of Projects and Fundraising:
H4 Transparency and Accounting
H4 Copyright Notice
Es befinden sich zu viele interne Links (418) auf der Seite.
Einige der Linktexte wiederholen sich.
Keiner der Linktexte ist zu lang.
Alle internen Links haben keine dynamischen Parameter.
Es befinden sich 11 externe Links auf der Seite.
LinkAttributeLinktext
http://www.clltopics.org/IMG-ALT CLL Topics Home
/Contents.htmlIMG-ALT Navigation
/Alert/index.htmlIMG-ALT Topics Alert
/Primer.htmlIMG-ALT Learning Tools
/AboutUs.htmlIMG-ALT About Us
/Feedback.htmlIMG-ALT Feedback
/Contents.htmlIMG-ALT Full Menu
/updates_subdomain/index.htmlIMG-ALT CLL Topics Updates
/updates_subdomain/index.htmlTextduplikat CLL Topics Updates
/updates_subdomain/index.htmlUpdates
/updates_subdomain/4699-news-y...News you can use
/Obituary.htmlMr. P. C. Venkat
/updates_subdomain/index.htmlTextduplikat CLL Topics Updates
/Obituary.htmlP. C. Venkat, 1949-2008
/MOABs/Veltuzumab.htmlVeltuzumab: Another Anti-CD20 Monoclonal in Clinical Trials
/SponsoredProjects/NKCellThera...NK-cell Therapy: Better than a transplant?
/DC/LivingLonger.htmlAre CLL Patients Living Longer?
/Chemo/SingleAgentFludarabine....Reason to Avoid Single Agent Fludarabine
/BMT/NCIMUD.htmlMUD Transplants at the NCI
/Chemo/Treanda.htmlTreanda: A Facelift for Bendamustine
/Complications/ITP.htmlITP: Immune Thrombocytopenia
/DC/Refractory.htmlRefractory CLL
/SponsoredProjects/JabNDab.htmlJab & Dab: We Have Liftoff!
/Alert/direct_display_alert_re...Quality of Life with CLL
/Campath/JumpingtheGun.htmlCampath: Jumping the Gun
/PhysCor/DrExpert.htmlWhat Say You, Dr. Expert?
/tchoices/RIUnderappreciated.htmlRadioimmunotherapy: Underappreciated
/Announcements/RICuts.htmlRadioimmunotherapy Reimbursement Cuts
/PI/Murky.htmlFISHing in Murky Waters
/BMT/CBTStateoftheArt.htmlCord Blood Transplants: State of the Art
/BMT/Catch22.htmlCatch 22 – The Transplant Minefield
/CI/StrategyTactics.htmlHarvey's Battle Plans
/MOABs/Bexxar.htmlBexxar: Radioimmunotherapy
/BMT/GVHDDevelopments.htmlGVHD: A Meaningful Advance
/Case_Studies/JennysStory.htmlJenny Tells the Forest Story
/ClinTrials/CAT8015.htmlCAT8015 – A Trojan Horse
/MOABs/Lumi.htmlLumiliximab: the Next Drug in CLL?
/Chemo/Revlimid.htmlRevlimid to the Rescue?
/ClinTrials/HuFLAnnouncement.htmlHuMax-CD20 in Pivotal Lymphoma Trial
/ClinTrials/HuFCAnnouncement.htmlHuMax-CD20 + FC Combination Trial
/SponsoredProjects/RplusFenret...Rituxan plus Fenretinide
/BMT/TransplantsAlmostFree.htmlTransplants Almost Free
/MeetingsConferences/ASH2006Hi...ASH 2006 Highlights
/Case_Studies/GregsStory.htmlGreg's Story: A Cautionary Tale
/Announcements/AgentOrange.htmlAgent Orange Update
http://www.clltopics.org/Anchor The Vitamin D Council
/TIS/Tregs.htmlTregs Revealed
/SponsoredProjects/Sponsorship...Fundraising and Sponsorship Philosophy
/Complications/MostatRisk.htmlWho Is Most at Risk?
/PhysCor/SteroidCampath.htmlSteroid-Campath Combinations
/SponsoredProjects/RituxanShav...CD20 Shaving with Rituxan
/Complications/mrsa.htmlSuper Bugs: Staph
/ClinTrials/HuMaxRisksRewards....HuMax-CD20: Risks & Rewards
/ClinTrials/SmarterMonoclonal....A Smarter Monoclonal
/Complications/EnemyWithin.htmlThe Enemy Within
/Complications/InfectiousCompl...Infectious Complications
/Complications/EpoGettingDarke...Caution on EPO
/tchoices/BestPractices.htmlStandards for Best Practices
/ClinTrials/HarveyIsBack.htmlHuMax & Genmab in the News
/SponsoredProjects/LHF.htmlImproving Immunizations
/datafiles/TestingthePowerofGr...WSJ Article on Topics
/Chemo/FCvsF.htmlF+C vs F
/Vaccines/VaccineTrials.htmlA Vaccine Trial for CLL
/Case_Studies/ForestBump.htmlForest Bump
/Rituxan/RituxanRoadBlock.htmlRituxan Road-block
/tchoices/BattleWar.htmlWinning the Battle but Losing the War?
/Phyto/LatestonGreenTea.htmlLatest on Green Tea
/ClinTrials/CTUPCRvsFCR.htmlClinical Trial Updates
/ClinTrials/FCRLite.htmlFCR Lite
/tchoices/RFRisks.htmlRF Risks & Benefits
/ClinTrials/HuMax.htmlHuMax Clinical Trial
/ChronInflam/AvianFlu.htmlAvian Flu and CLL
/PI/MCLWolf.htmlMCL – a Wolf in CLL Clothing
/ClinTrials/Bcl2Target.htmlTargeting Bcl-2
/ChronInflam/FluPrep.htmlFlu Preparedness
/CTLTherapy/CD20Target.htmlCD-20 Targeted T-Cell Therapy
/SponsoredProjects/PAlphaKicko...Project Alpha Kickoff
/ClinTrials/MplusFCRBrit.htmlFMC + R Brit. Version
/CaseStudies/ConventionalWisdo...Death by Conventional Wisdom
/ClinTrials/MitoxantroneplusFC...More on Mitoxantrone + FCR
/ClinTrials/MitoxantroneplusFC...Mitoxantrone + FRC
/tchoices/RiskAdaptedStrategie...Risk-adapted Strategies
/BMT/GVHD.htmlGraft versus Host Disease
/BMT/OnlyRealCure.htmlOnly Real Cure
/ClinTrials/17AAGClinTrial.html17-AAG Clinical Trial
/Chemo/17AAG.html17-AAG
/Campath/CampathplusGCSF.htmlCampath plus G-CSF
/PhysCor/FrankArbiserInterview...Honokiol: Expert Interview
/Phyto/honokiol.htmlHonokiol
/tchoices/IVIgBenefits.htmlPossible Benefits of IVIg
/PI/PrognosticandMonitoringTes...Test Packages Available
/Announcements/CLLGlobalResear...CLL Global
/ClinTrials/RituxanplusCampath...Rituxan + Short Duration Campath
/Campath/ProlongedSurvival.htmlCampath – Good News
/DC/DawnofaNewEra.htmlDawn of a New Era
/PI/ProgressonPrognostics.htmlTesting Solutions
/PatCor/gettingagrip.htmlGetting a Grip
/PhysCor/AWTY.htmlAre We There Yet?
/Phyto/Omega3.htmlOmega-3 Fatty Acids
/Complications/RealPain.htmlA Real Pain in the Mouth
/BMT/MatchingMadeSimple.htmlMatching Made Simple
/MOABs/SonsofRituxanandCampath...Sons of Rituxan & Campath
/MeetingsConferences/ASH2004Hi...ASH 2004 Highlights
/CellBio/Epigenetics.htmlEpigenetics
/tchoices/ShoppingForTherapies...Shopping for Therapies
/Alert/direct_display_alert_re...Those Aches and Pains
/Chemo/TargetMitochondrion.htmlTarget Mitochondrion
/PI/ZAP-70_IgVH.htmlZAP-70 & IgVH Gene Mutation
/Complications/AIHA.htmlAIHA
/PatCor/diagnosingyourdoctor.htmlDiagnosing Your Doctor
/DC/WorstDay.htmlNot the Worst Day
/PhysCor/FamilialCLL.htmlFamilial CLL
/Rituxan/NeupogenBoosterR.htmlNeupogen Boosts Rituxan
/VitaminD3/EssentialforHealth....Vitamin D3
/tchoices/NotGoldStandard.htmlF Monotherapy: Not Gold Standard
/Campath/campath_consolidation...Campath Consolidation
/Complications/Dying.htmlDying to Get a Tan?
/tchoices/NeedtoKnow.htmlNeed To Know
/PI/FISHingforAnswers.htmlFISH-ing for Answers
/DC/ClonalEvolution.htmlClonal Evolution
/CellBio/AdhesionHomingResista...Resistance to Therapy
/PI/Type.htmlBuckets: What Type of CLL Do You Have?
/BMT/PrimeronSCTs.htmlPrimer on Stem Cell Transplants
/Contents.htmlTable of Contents
/Alert/index.htmlTopics Alert!
/Alert/index.htmlIMG-ALT CLL Topics World Balloon
/Alert/index.htmlTextduplikat Topics Alert
/updates_subdomain/index.htmlTextduplikat CLL Topics Updates
/Alert/alert_archive.htmlAlert Archive
/Contents.htmlContents
http://www.clltopics.org/Anchor customized site search form
/Feedback.htmlTextduplikat Feedback
/AboutUs.htmlTextduplikat About Us
/AboutUs.htmlTextduplikat About Us
/datafiles/SpringMayoMag05_CLL...Information Empowers Leukemia Patients
/datafiles/TestingthePowerofGr...Testing the Power of Green Tea
/patients_corner.htmlPatients' Corner
/SupportGroups.htmlSupport Groups
/TechnicalNotes.htmlNavigation Notes
/Contents.htmlTextduplikat Contents
/Primer.htmlA CLL Primer
/YourCharts.htmlYour Charts
/Reference.htmlReference
/Textbooks.htmlTextbooks
/search_tools.htmlSearch Tools
/Donations.htmlDonations
/CurrentArticles.htmlCurrent Articles
/Contents.htmlTextduplikat Contents
/Donations.htmlTextduplikat Donations
/Acknowledgements.htmlAcknowledgements
/SponsoredProjects.htmlSponsored Projects
https://www.csgoskinsites.com/...Neues Fenster Extern csgo betting
/datafiles/F2007.pdfFiscal 2007 Statement
/datafiles/F2006.pdfFiscal 2006 Statement
/datafiles/F2005.pdfFiscal 2005 Statement
/datafiles/F2004.pdfFiscal 2004 Statement
/datafiles/F2003.pdfFiscal 2003 Statement
/datafiles/AR2007.pdfAnnual Report to the Board for 2007
/datafiles/AR2006.pdfAnnual Report to the Board for 2006
/datafiles/AR2005.pdfAnnual Report to the Board for 2005
/datafiles/AR2004.pdfAnnual Report to the Board for 2004
/datafiles/ArticlesofIncorpora...Articles of Incorporation
/datafiles/BylawsAsAmended.pdfBylaws
/datafiles/PublicCharityStatus...Ruling Confirming Status as Public Charity
/datafiles/AdvRulingLetter.pdfIRS Tax Exemption Letter
/datafiles/ApplicationAdvRulin...Application for Tax Exemption
/search_tools.htmlTextduplikat Search Tools
A-TITLE Search Tools
/YourCharts.htmlTextduplikat Your Charts
A-TITLE Your Charts
/TechnicalNotes.htmlTextduplikat Navigation Notes
A-TITLE Navigation Notes
/Reference.htmlOnline Reference
A-TITLE Online Reference
/Textbooks.htmlTextduplikat Textbooks
A-TITLE Textbooks
/Primer.htmlCLL Primer
A-TITLE CLL Primer
/Contents.htmlSite Map
A-TITLE Site Map
/Alert/alert_archive.htmlListing of Past Alerts
/search_tools.htmladvanced search form
/Obituary.htmlIMG-ALT Obituary
/Obituary.htmlP. C. Venkat
/journal_subdomain/index.htmlHarvey's Journal
/updates_subdomain/index.htmlTextduplikat CLL Topics Updates
/Obituary.htmlTextduplikat IMG-ALT Obituary
/MOABs/Veltuzumab.htmlIMG-ALT Purple Pentacube
/MOABs/Veltuzumab.htmlTextduplikat Veltuzumab: Another Anti-CD20 Monoclonal in Clinical Trials
/SponsoredProjects/NKCellThera...IMG-ALT Mandelbrot Part
/SponsoredProjects/NKCellThera...Textduplikat NK-cell Therapy: Better than a transplant?
/DC/LivingLonger.htmlIMG-ALT long life
/DC/LivingLonger.htmlTextduplikat Are CLL Patients Living Longer?
/Chemo/SingleAgentFludarabine....IMG-ALT red
/Chemo/SingleAgentFludarabine....Single Agent Fludarabine: Definitely Not the Gold Standard
/BMT/NCIMUD.htmlIMG-ALT hematopoeitic stem cells
/BMT/NCIMUD.htmlTextduplikat MUD Transplants at the NCI
/Chemo/Treanda.htmlIMG-ALT splash
/Chemo/Treanda.htmlTextduplikat Treanda: A Facelift for Bendamustine
/Complications/ITP.htmlIMG-ALT abstract
/Complications/ITP.htmlTextduplikat ITP: Immune Thrombocytopenia
/DC/Refractory.htmlIMG-ALT Progressive Spiral
/DC/Refractory.htmlTextduplikat Refractory CLL
/SponsoredProjects/JabNDab.htmlIMG-ALT Tiffany glass
/SponsoredProjects/LHF.htmlImproving Routine Immunizations
/SponsoredProjects/JabNDab.htmlTextduplikat Jab & Dab: We Have Liftoff!
https://twin.com/nzNeues Fenster Extern online casino nz
/Alert/direct_display_alert_re...IMG-ALT QOL Survey
/Alert/direct_display_alert_re...Topics Alert #253: Quality of Life with CLL
/Campath/JumpingtheGun.htmlIMG-ALT useful comparison?
/Campath/JumpingtheGun.htmlJumping the Gun
/PhysCor/DrExpert.htmlTextduplikat IMG-ALT hematopoeitic stem cells
/PhysCor/DrExpert.htmlTextduplikat What Say You, Dr. Expert?
/tchoices/RIUnderappreciated.htmlIMG-ALT rings
/tchoices/RIUnderappreciated.htmlRadioimmunotherapy: Underappreciated Option?
/Announcements/RICuts.htmlIMG-ALT faded glass
/Announcements/RICuts.htmlTextduplikat Radioimmunotherapy Reimbursement Cuts
/PI/Murky.htmlIMG-ALT shell glass
/PI/Murky.htmlTextduplikat FISHing in Murky Waters
/BMT/CBTStateoftheArt.htmlIMG-ALT rainbow
/BMT/CBTStateoftheArt.htmlTextduplikat Cord Blood Transplants: State of the Art
/BMT/Catch22.htmlIMG-ALT dial
/BMT/Catch22.htmlTextduplikat Catch 22 – The Transplant Minefield
/CI/StrategyTactics.htmlIMG-ALT Glass
/CI/StrategyTactics.htmlStrategy and Tactics
/don/NotesonFundraising.htmlfundraising efforts
/MOABs/Bexxar.htmlIMG-ALT X-ray mouse
/MOABs/Bexxar.htmlBexxar: An Introduction to Radioimmunotherapy
/BMT/GVHDDevelopments.htmlIMG-ALT art glass
/BMT/GVHDDevelopments.htmlGVHD: A Pebble in the Transplant Shoe
/Case_Studies/JennysStory.htmlTextduplikat IMG-ALT rings
/ClinTrials/FCRLite.htmlTextduplikat FCR Lite
/Case_Studies/ForestBump.htmlTextduplikat Forest Bump
/Case_Studies/JennysStory.htmlTextduplikat Jenny Tells the Forest Story
/ClinTrials/CAT8015.htmlIMG-ALT equine outline
/ClinTrials/CAT8015.htmlTextduplikat CAT8015 – A Trojan Horse
/MOABs/Lumi.htmlIMG-ALT new light
/MOABs/Lumi.htmlLumiliximab: The Next Drug in CLL?
/Chemo/Revlimid.htmlIMG-ALT molecular markers
/Chemo/Revlimid.htmlTextduplikat Revlimid to the Rescue?
/ClinTrials/HuFLAnnouncement.htmlIMG-ALT electric cascade
/ClinTrials/HuFLAnnouncement.htmlHuMax-CD20 Monotherapy in Refractory Follicular Lymphoma
/ClinTrials/HuFCAnnouncement.htmlIMG-ALT fractal cascade
/ClinTrials/HuFCAnnouncement.htmlHuMax+FC Announcement
/SponsoredProjects/RplusFenret...IMG-ALT Dawn Sky
/SponsoredProjects/RplusFenret...Rituxan plus Fenretinide: a Match Made in Heaven?
/BMT/TransplantsAlmostFree.htmlIMG-ALT stem cells
/BMT/TransplantsAlmostFree.htmlStem Cell Transplants - Free of Charge (Almost!)
/MeetingsConferences/ASH2006Hi...IMG-ALT Orlando CC
/MeetingsConferences/ASH2006Hi...Textduplikat ASH 2006 Highlights
/Case_Studies/GregsStory.htmlIMG-ALT fractal blue rose
/Case_Studies/GregsStory.htmlGreg's Story
/TIS/Tregs.htmlIMG-ALT T-regs
/TIS/Tregs.htmlTregs Revealed.
/SponsoredProjects/Sponsorship...IMG-ALT x-ray abacus
/SponsoredProjects/Sponsorship...Our Fundraising and Sponsorship Philosophy
/Complications/MostatRisk.htmlIMG-ALT capsule
/Complications/MostatRisk.htmlTextduplikat Who Is Most at Risk?
/PhysCor/SteroidCampath.htmlIMG-ALT p53 Gene Map
/PhysCor/SteroidCampath.htmlTextduplikat Steroid-Campath Combinations
/SponsoredProjects/RituxanShav...IMG-ALT epitopes
/SponsoredProjects/RituxanShav...Textduplikat CD20 Shaving with Rituxan
/Complications/mrsa.htmlIMG-ALT bacterial culture
/Complications/mrsa.htmlThe Dangers of Drug Resistant Bacterial Infections
/ClinTrials/HuMaxRisksRewards....Textduplikat IMG-ALT fractal cascade
/ClinTrials/HuMaxRisksRewards....HuMax-CD20 Risks and Rewards
/ClinTrials/SmarterMonoclonal....Textduplikat IMG-ALT abstract
/ClinTrials/SmarterMonoclonal....A Smarter Monoclonal on Trial
/Complications/EnemyWithin.htmlIMG-ALT EBV
/Complications/EnemyWithin.htmlTextduplikat The Enemy Within
/Complications/InfectiousCompl...IMG-ALT Virus in Blue
/Complications/InfectiousCompl...Infectious Complications of CLL
/Complications/EpoGettingDarke...IMG-ALT RBCs
/Complications/EpoGettingDarke...The Dark Side of EPO - Getting Darker
/ClinTrials/HarveyIsBack.htmlIMG-ALT companions
/ClinTrials/HarveyIsBack.htmlGenmab in the News
/SponsoredProjects/LHF.htmlIMG-ALT tomato button
/SponsoredProjects/LHF.htmlTextduplikat Improving Immunizations
/Chemo/FCvsF.htmlIMG-ALT apples to apples
/Chemo/FCvsF.htmlTextduplikat F+C vs F
/Vaccines/VaccineTrials.htmlIMG-ALT Leonardo Proportion Study
/Vaccines/VaccineTrials.htmlA Vaccine Trial for CLL Patients
/CaseStudies/ForestBump.htmlIMG-ALT sneakers
/CaseStudies/ForestBump.htmlTextduplikat Forest Bump
https://fi.twin.com/Neues Fenster Extern Subdomain netticasino
/Rituxan/RituxanRoadBlock.htmlIMG-ALT traffic barrier
/Rituxan/RituxanRoadBlock.htmlHarvey Runs into a Road-block
/tchoices/BattleWar.htmlIMG-ALT cadeseus
/tchoices/BattleWar.htmlTextduplikat Winning the Battle but Losing the War?
/Phyto/LatestonGreenTea.htmlIMG-ALT EGCG molecule
/Phyto/LatestonGreenTea.htmlTextduplikat Latest on Green Tea
/ClinTrials/CTUPCRvsFCR.htmlIMG-ALT apples and kumquat
/ClinTrials/CTUPCRvsFCR.htmlTextduplikat Clinical Trial Updates
/ClinTrials/FCRLite.htmlIMG-ALT UPMC Cancer Center
/ClinTrials/FCRLite.htmlTextduplikat FCR Lite
https://de.twin.com/slotsNeues Fenster Extern Subdomain Slot Spiele
/tchoices/RFRisks.htmlIMG-ALT roulette
/tchoices/RFRisks.htmlnew article on RF Therapy
/ClinTrials/HuMax.htmlIMG-ALT half-full glass
/ClinTrials/HuMax.htmlResults from GenMab's HuMax Clinical Trial
/ChronInflam/AvianFlu.htmlIMG-ALT H5N1
/ChronInflam/AvianFlu.htmlTextduplikat Avian Flu and CLL
/PI/MCLWolf.htmlIMG-ALT cute wolf
/PI/MCLWolf.htmlMCL - a Wolf in CLL Clothing
/ClinTrials/Bcl2Target.htmlIMG-ALT bcl2
/ClinTrials/Bcl2Target.htmlTextduplikat Targeting Bcl-2
/ChronInflam/FluPrep.htmlIMG-ALT flu virus
/ChronInflam/FluPrep.htmlTextduplikat Flu Preparedness
/CTLTherapy/CD20Target.htmlIMG-ALT T-cell red
/CTLTherapy/CD20Target.htmlAutologous CD-20 Targeted T-Cell Therapy
/SponsoredProjects/PAlphaKicko...IMG-ALT EGCG
/SponsoredProjects/PAlphaKicko...Textduplikat Project Alpha Kickoff
/Case_Studies/ConventionalWisd...IMG-ALT labcoat
/Case_Studies/ConventionalWisd...Textduplikat Death by Conventional Wisdom
/tchoices/RiskAdaptedStrategie...IMG-ALT binoculars
/tchoices/RiskAdaptedStrategie...Textduplikat Risk-adapted Strategies
/BMT/GVHD.htmlIMG-ALT transplants
/BMT/GVHD.htmlThis article
/BMT/OnlyRealCure.htmlIMG-ALT hematopoietic stem cells
/BMT/OnlyRealCure.htmlThe Only Real Cure Out There, for Now
/ClinTrials/17AAGClinTrial.htmlIMG-ALT hsp90
/ClinTrials/17AAGClinTrial.html17-AAG - An Important New Trial Has Been Announced
/Chemo/17AAG.htmlIMG-ALT Yellow Brick Road
/Chemo/17AAG.htmlTextduplikat 17-AAG
/Campath/CampathplusGCSF.htmlIMG-ALT molecular montage
/Campath/CampathplusGCSF.htmlTextduplikat Campath plus G-CSF
/tchoices/IVIgBenefits.htmlIMG-ALT antibody diagram
/tchoices/IVIgBenefits.htmlTextduplikat Possible Benefits of IVIg
/PI/PrognosticandMonitoringTes...IMG-ALT prognostic symbols
/PI/PrognosticandMonitoringTes...Prognostic and Monitoring Tests
/ClinTrials/RituxanplusCampath...IMG-ALT brick road
/ClinTrials/RituxanplusCampath...Clinical Trial to Test Rituxan plus Short Duration Campath
/Campath/ProlongedSurvival.htmlIMG-ALT Campath Molecule
/Campath/ProlongedSurvival.htmlGood News for the Tough Cases
https://ezy.com/Neues Fenster Extern csgo case
/DC/DawnofaNewEra.htmlIMG-ALT Staging is passe
/DC/DawnofaNewEra.htmlThe Dawn of a New Era
/PI/ProgressonPrognostics.htmlTextduplikat IMG-ALT prognostic symbols
/PI/ProgressonPrognostics.htmlProgress on Prognostics
/PhysCor/AWTY.htmlIMG-ALT Is FCR a Cure
/PhysCor/AWTY.htmlTextduplikat Are We There Yet?
https://twin.com/slotsNeues Fenster Extern free slots
/Phyto/Omega3.htmlIMG-ALT symbolic fish
/Phyto/Omega3.htmlTextduplikat Omega-3 Fatty Acids
https://www.onlinecasinolovers...Neues Fenster Extern best online casino uk
/Complications/RealPain.htmlIMG-ALT oral care
/Complications/RealPain.htmlTextduplikat A Real Pain in the Mouth
/BMT/MatchingMadeSimple.htmlIMG-ALT jigsaw puzzle
/BMT/MatchingMadeSimple.htmlTextduplikat Matching Made Simple
/MOABs/SonsofRituxanandCampath...IMG-ALT lobster
/MOABs/SonsofRituxanandCampath...Sons of Rituxan and Campath
https://www.leon.ru/mobileNeues Fenster Extern букмекерская контора
/CellBio/Epigenetics.htmlIMG-ALT chromatin
/CellBio/Epigenetics.htmlTextduplikat Epigenetics
/tchoices/ShoppingForTherapies...IMG-ALT key lock puzzle
/tchoices/ShoppingForTherapies...Shopping for the Therapy that is Right for You
http://www.clltopics.org/Anchor Kein Text
/Primer.htmlTextduplikat A CLL Primer
/PI/Type.htmlWhat Type of CLL
/Alert/alert_archive.htmlTopics Alerts Archive
/YourCharts.htmlTextduplikat Your Charts
/BestPractices.htmlBest Practices
/tchoices/ShoppingForTherapies...Textduplikat Shopping for Therapies
/journal_subdomain/index.htmlIMG-ALT journal
/journal_subdomain/index.htmlonline journal
/SponsoredProjects.htmlIMG-ALT Six Point Star
https://br.twin.com/Neues Fenster Extern Subdomain cassino online
/SponsoredProjects.htmlCLL Topics Sponsored Clinical Trials
/SponsoredProjects/Sponsorship...Our Sponsorship Philosophy
http://content.nejm.org/cgi/re...Extern Subdomain full editorial
/RituxanTherapy.htmlRituxan
/Fludarabine.htmlFludarabine
/CampathTherapy.htmlCampath
/HuMaxCD20.htmlHuMax-CD20
/Chemotherapy.htmlTraditional Chemotherapy
/Transplants.htmlStem Cell Transplants
/Vaccines.htmlVaccines
/tchoices/GeneTherapy.htmlGene Therapy
/CTLTherapy.htmlCTL Therapy
/Angiogenesis.htmlAngiogenesis
/Chemoprevention.htmlPhytochemicals
/Vitamin_d3.htmlTextduplikat Vitamin D3
/BestPractices.htmlBest Practices in CLL
/don/Update.htmlDonation Status
/Acknowledgements.htmlTextduplikat Acknowledgements
/Reference.htmlTextduplikat Reference
/Reference.htmlmanaging infections in the immune compromised patient
/patients_corner.htmlTextduplikat Patients' Corner
/PhysiciansCorner.htmlPhysicians' Corner
/PhysCor/SteroidCampath.htmlsteroid-Campath combinations
/PhysCor/AWTY.htmlTextduplikat Are We There Yet?
/PhysCor/FamilialCLL.htmlTextduplikat Familial CLL
/Reference.htmlTextduplikat Reference
/Reference.htmlMemorial Sloan-Kettering
/Chemoprevention.htmlPhytochemicals, Nutrition and Chemoprevention
/Phyto/DrinkingGreenTea.htmlDo You Like Drinking Green Tea?
/Vitamin_d3.htmlTextduplikat Vitamin D3
/VitaminD3/EssentialforHealth....IMG-ALT spiral
/VitaminD3/EssentialforHealth....Vitamin D3: Essential for Health
/Announcements/AgentOrange.htmlTextduplikat Agent Orange Update
/Announcements/AgentOrange.htmlIMG-ALT Vietnam
/tchoices/NeedtoKnow.htmlIMG-ALT mayo building
/tchoices/NeedtoKnow.html"Need to Know"
/PI/Type.htmlIMG-ALT multicolor fixture
/PI/Type.htmlWhat Type of CLL Do You Have?
/PI/FISHingforAnswers.htmlIMG-ALT fish
/PI/FISHingforAnswers.htmlTextduplikat FISH-ing for Answers
/DC/WorstDay.htmlNot the Worst Day of Your Life
IMG-ALT ducks
/Campath/CampathLookingBetter....IMG-ALT Campath molecule
/Campath/CampathLookingBetter....Campath Looking Better and Better
/PI/PrognosisatDiagnosis.htmlIMG-ALT flow cytometry
/PI/PrognosisatDiagnosis.htmlPrognosis at Diagnosis
/Chemo/DeliveryMethods.htmlIMG-ALT lymphatic system
/Chemo/DeliveryMethods.htmlThe "How" Is Often as Important as the "What"
/CellBio/AdhesionHomingResista...IMG-ALT cell micrograph
/CellBio/AdhesionHomingResista...Adhesion, Homing and Resistance to Therapy
/CellBio/CytogeneticsATMP53.htmlIMG-ALT gene plot
/CellBio/CytogeneticsATMP53.htmlCytogenetics of ATM and TP53
/ChronInflam/Pulmonary.htmlTextduplikat IMG-ALT cell micrograph
/ChronInflam/Pulmonary.htmlRole of Pulmonary Inflammation in CLL
/Complications/Dying.htmlIMG-ALT sunsquare
/Complications/Dying.htmlTextduplikat Dying to Get a Tan?
/Chemo/TargetMitochondrion.htmlIMG-ALT mitochondrion
/Chemo/TargetMitochondrion.htmlExciting New Drugs on the Horizon
/Complications/AIHA.htmlTextduplikat IMG-ALT RBCs
/Complications/AIHA.htmlAIHA: Auto-Immune Hemolytic Anemia
/Complications/EpoDarkSide.htmlIMG-ALT EPO
/Complications/EpoDarkSide.htmlThe Dark Side of Epoetin
/ChronInflam/WhatUCanDo.htmlIMG-ALT inflammation
/ChronInflam/WhatUCanDo.htmlCLL, Chronic Inflammation and What You Can Do About It
/DC/ClonalEvolution.htmlIMG-ALT evolution diagram
/DC/ClonalEvolution.htmlTextduplikat Clonal Evolution
http://www.clltopics.org/RHK.htmlTextduplikat IMG-ALT companions
/CI/DifficultCaseRHK.htmlThe Difficult Case of the Round-headed Kid
http://www.clltopics.org/RHK.htmlRHK Saga
https://www.bästacasinoonline....Neues Fenster Extern Subdomain bästa casino online

Serverkonfiguration

HTTP-Weiterleitungen
(Extrem wichtig)
Die Seite leitet weiter auf "http://www.clltopics.org/"
HTTP-Header
(Wichtig)
Die HTML-Seite sollten mittels GZip Komprimierung übertragen werden.
Es wird kein X-Powered HTTP-Header mitgesendet.
Performance
(Wenig wichtig)
Die Webseite lädt 4 CSS Dateien, dies kann die Ladezeit negativ beeinträchtigen.
Die Webseite lädt 4 Javascript Dateien, dies kann die Ladezeit negativ beeinträchtigen.
Die Antwortzeit der HTML-Seite ist mit 0,05 Sekunden unter der Zielmarke von 0,40 Sekunden.
Die Dateigröße des HTML-Dokuments ist mit 167 kB in Ordnung.

HTTP-Header

NameWert
dateMon, 27 Jan 2020 18:52:29 GMT
serverApache
last-modifiedTue, 12 Nov 2019 14:48:49 GMT
accept-rangesbytes
content-length171123
content-typetext/html
statuscode200
http_versionHTTP/1.1

Externe Faktoren

Blacklists
(Extrem wichtig)
Die Seite wird von Webwiki nicht als "nur für Erwachsene" eingestuft.
Die Seite ist nicht auf der Shallalist verzeichnet.
Die Seite ist exzellent von anderen Webseiten verlinkt.
Die Seite hat Backlinks von 200 verweisenden Domains.
Die Seite hat insgesamt 2.246 Backlinks.
Die Seite hat Backlinks von 171 verschiedenen IP Adressen.
Verbreitung bei Facebook
(Wenig wichtig)
Die Seite ist bei Facebook kaum relevant.
Eintrag bei Webwiki
(Nice to have)
Die Seite ist bei Webwiki verzeichnet.

Links von Wikipedia

Es wurden keine Links von Wikipedia gefunden.

Robots.txt

Sitemap: http://clltopics.org/sitemap.xml

Popularität bei Facebook

Shares / Likes / Kommentare
0

Es werden nur die Daten zu der angegebenen URL abgefragt und nicht zu einer eventuell vorhandenen und auf der Seite verlinkten Facebook Seite.

Suchvorschau

www.clltopics.org
CLL Topics: Therapies, Research and Patient Education for Chronic L...
CLL Topics dedicated to the fight against chronic lymphocytic leukemia - patient education and support, clinical research and new therapies

Wichtigste Suchbegriffe

Folgende Keywords hat Seobility erkannt. Überprüfe die Optimierung dieser Keywords für Deine Seite.

KeywordErgebnisPrüfen
CLL95%Check
Topics95%Check
CLL Topics95%Check
CLL Research78%Check
in CLL75%Check
CLL patient73%Check
by CLL Topics73%Check
CLL is67%Check
Topics Alert63%Check
in an62%Check

Analysiere jetzt kostenlos bis zu 1.000 Unterseiten von clltopics.org!

Kostenlos registrieren
Die Nutzung des Basis Accounts ist zeitlich unbegrenzt möglich